Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0034063 (
pulmonary edema
)
10,665
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
This study was performed to demonstrate an experimental procedure of
pulmonary edema
induced by angiotensin I (AT I) in rats and to elucidate the mechanism of hemodynamic
pulmonary edema
. In the previous pilot study, 20 microg/kg of AT I was found to be an adequate dose for inducing
pulmonary edema
. To elucidate the mechanism of AT I
pulmonary edema
and protective measures against it, we observed the effects of captopril (CAP, 5 and 10 mg/kg), an angiotensin converting enzyme inhibitor; losartan (LOS, 10 mg/kg), an angiotensin II (AT II)-receptor antagonist; and phentolamine (
PHE
, 10 mg/kg), an alpha-adrenergic receptor blocker, on AT I-induced
pulmonary edema
in rats. Similarly, we also observed the effects of CAP (10 and 20 mg/kg) on
pulmonary edema
induced by 25 microg/kg of adrenaline (ADR) in rats. The development of AT I-induced
pulmonary edema
was significantly suppressed by CAP and LOS, but was unaffected by
PHE
. In contrast, the development of ADR-induced
pulmonary edema
was not suppressed by CAP. These results suggest that AT I-induced
pulmonary edema
is developed via the AT II and a specific AT II-receptor, without the indirect action of adrenaline.
...
PMID:Pulmonary edema induced by angiotensin I in rats. 951 4
There is a paucity of studies, clinical and experimental, attesting to the benefit of cerebral perfusion pressure (CPP) directed pressor therapy following traumatic brain injury (TBI). The current study evaluates this therapy in a swine model of TBI and hypotension. Forty-five anesthetized and ventilated swine received TBI followed by a 45% blood volume bleed. After 1 h, all animals were resuscitated with 0.9% sodium chloride equal to three times the shed blood volume. The experimental group (
PHE
) received phenylephrine to maintain CPP > 80 mm Hg; the control group (SAL) did not. Outcomes in the first phase (n = 33) of the study were as follows: cerebro-venous oxygen saturation (S(cv)O(2)), cerebro-vascular carbon dioxide reactivity (DeltaS(cv)O(2)), and brain structural damage (beta-amyloid precursor protein [betaAPP] immunoreactivity). In the second phase (n = 12) of the study, extravascular blood free water (EVBFW) was measured in the brain and lung. After resuscitation, intracranial and mean arterial pressures were >15 and >80 mm Hg, respectively, in both groups. CPP declined to 64 +/- 5 mm Hg in the SAL group, despite fluid supplements. CPP was maintained at >80 mm Hg with pressors in the
PHE
group.
PHE
animals maintained better S(cv)O(2) (p < 0.05 at 180, 210, 240, 270, and 300 min post-TBI). At baseline, 5% CO(2) evoked a 16 +/- 4% increase in S(cv)O(2), indicating cerebral vasodilatation and luxury perfusion. By 240 min, this response was absent in SAL animals and preserved in
PHE
animals (p < 0.05). Brain EVBFW was higher in SAL animals; however, lung EVBFW was higher in
PHE
animals. There was no difference in betaAPP immunoreactivity between the SAL and
PHE
groups (p > 0.05). In this swine model of TBI and hypotension, CPP directed pressor therapy improved brain oxygenation and maintained cerebro-vascular CO(2) reactivity. Brain edema was lower, but
lung edema
was greater, suggesting a higher propensity for pulmonary complications.
...
PMID:Cerebral perfusion pressure directed therapy following traumatic brain injury and hypotension in swine. 1457 61